Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug:53:209-216.
doi: 10.1016/j.coi.2018.08.002. Epub 2018 Sep 3.

When designing vaccines, consider the starting material: the human B cell repertoire

Affiliations
Review

When designing vaccines, consider the starting material: the human B cell repertoire

Colin Havenar-Daughton et al. Curr Opin Immunol. 2018 Aug.

Abstract

Most viral vaccines provide protection from infection through the generation of neutralizing antibodies (nAbs). The repertoire of B cells responding to immunization is the starting material from which nAbs eventually arise. Immunization strategies are increasingly targeting precise B cell specificities to mimic nAbs generated during natural infection, in an effort to maximize the potency of the vaccine-elicited Ab response. An understanding of the human B cell specificities capable of immunogen recognition can aid in immunogen design and inform decision-making for clinical advancement. Here, we review what is known about antigen-specific and epitope-specific naive B cell repertoires in humans and mice, and we consider the challenges for identifying and analyzing antigen-specific naive B cell repertoires. Finally, we provide a framework for further exploration, interpretation, utilization of the B cell repertoire to facilitate vaccine discovery.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Classification of eOD-GT8 specific naive human B cells by epitope specificity and BCR sequence characteristics. The colored area represents the eOD-GT8 specific naive human B cell repertoire. ‘On-target’ naive B cells (blue) with BCR sequence characteristics (VH1-2+ and 5aa L-CDR3 length) and CD4bs epitope specificity are classified as VRC01-class naive B cells.
Figure 2
Figure 2
Consideration of B cell frequencies and bnAb coverage. ‘Potential bnAb precursor frequency’ is plotted as the inverse of naive B cell frequency (i.e. 1 in ‘x’ number of B cells) for each class or subclass. The IOMA class naive B cell frequency may be underestimated, as eOD-GT8 was not specifically designed to target IOMA-like cells. However, based on human B cell repertoire bioinformatics, the frequency of the IOMA lambda LC is expected to be lower than or similar to that of the kappa VRC01-class LCs, as lambda LCs are longer and less common than kappa LCs. BnAb class and subclass percentage neutralization coverage are plotted using values of the named bnAb (i.e. ‘VRC01 class’ coverage value is the neutralization of VRC01 bnAb [47]). Detected subclasses are shown in blue [21]. Naive B cell subclasses that are below the limit of detection are plotted in the grayed area (plotted values vary due to differences in experimental approach).

References

    1. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17:1055–1065. - PMC - PubMed
    1. Burton D.R. What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise. Cold Spring Harb Perspect Biol. 2017;9:a030262. - PMC - PubMed
    1. Rappuoli R., Bottomley M.J., D’Oro U., Finco O., De Gregorio E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J Exp Med. 2016;213:469–481. - PMC - PubMed
    1. Kwong P.D. What are the most powerful immunogen design vaccine strategies? A structural biologist’s perspective. Cold Spring Harb Perspect Biol. 2017;9:a029470. - PMC - PubMed
    1. Jardine J.G., Sok D., Julien J.-P., Briney B., Sarkar A., Liang C.-H., Scherer E.A., Henry Dunand C.J., Adachi Y., Diwanji D. Minimally mutated HIV-1 broadly neutralizing antibodies to guide reductionist vaccine design. PLoS Pathog. 2016;12:e1005815. - PMC - PubMed

Publication types